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ur understanding of the impact of diabetes on
organ function has been evolving since the
discovery of insulin in the 1920s. At that time
insulin was a miracle drug that appeared to
cure diabetes, but over time it became clear that death and
disability from diabetes complications involving the eyes,
kidneys, peripheral nerves, heart, and vasculature could
occur even with treatment. With the improvement in
diabetes care over the past 20 years, fewer patients are
developing the traditional diabetes complications. How-
ever, as people live long and well with the disease, it has
become apparent that diabetes can alter function and
structure in tissues not typically associated with compli-
cations such as the brain and bone. Alteration in brain
structure and function are particularly of concern because
of the impact of dementia and cognitive dysfunction on
overall quality of life.
From large epidemiological studies, it has been demon-
strated that both vascular and Alzheimer’s dementia are
more common in patients with type 2 diabetes (1). Why
this might be true has been difﬁcult to deﬁne. Certainly
these patients can be expected to have more risk factors
such as previous cardiovascular disease, history of hyper-
tension, and dyslipidemia than aged matched control
subjects, but when these variables are controlled, the risk
for patients with diabetes appears to be higher than that of
other subject groups. Persistent hyperglycemia appears to
play an important role in cerebral dysfunction. Many years
ago, Reaven et al. (2) demonstrated that performance on
cognitive tasks assessing learning, reasoning, and complex
psychomotor performance was inversely related to glyce-
mic control in a small population of subjects with type 2
diabetes. This issue was recently readdressed in the much
larger ACCORD population, where an elevated A1C was
found to be linked to reduced performance on neurocog-
nitive tests assessing memory, learning, and executive
functions in nearly 3,000 subjects with type 2 diabetes (3).
However, the relevance of these observations to younger
patients with type 2 diabetes and to patients with type 1
diabetes who may have fewer cardiovascular risk factors
is uncertain. Is the dementia and cognitive dysfunction
identiﬁed in elderly subjects with type 2 diabetes related to
their comorbidities and age, or is it the result of a
diabetes-related process that begins years earlier?
From studies performed in adults with type 1 diabetes,
we now know that reductions in measures of motor speed
and psychomotor efﬁciency can be seen in patients in
midlife (4). These neurocognitive changes have been as-
sociated with a reduction in white matter volume or an
alteration in white matter microstructure in some (5,6) but
not all (7,8) investigations. Reduction in gray matter
density in brain regions responsible for language process-
ing and memory (8) and generalized atrophy (9) have also
been identiﬁed in young adults with long-standing type 1
diabetes. Patients with chronic hyperglycemia (10), early
onset of disease (11), or recurrent severe hypoglycemia
(12) appear to be at particular risk for the development of
changes in brain structure and function over time, al-
though these associations have not been consistently
observed in all groups of subjects with type 1 diabetes who
have been investigated (7,8). If the abnormalities seen in
these adults with type 1 diabetes are speciﬁc to diabetes,
they may also be seen in younger patients with type 2
diabetes. Careful assessment of cerebral structure and
function in young adults with type 2 diabetes but without
other comorbidities that increase the risk of vascular
disease could help us understand the impact of diabetes
on the brain. Examination of children with diabetes may
also provide more insight into the speciﬁc effects of
diabetes on the brain.
In the current issue of Diabetes, Hershey et al. (13)
present imaging data collected from a large cohort of
children with type 1 diabetes. They made the surprising
observation that hippocampal volumes were increased in
the children with the largest number of severe hypoglyce-
mic episodes. These observations demonstrate the sensi-
tivity of the hippocampus to acute hypoglycemia but are
contrary to the data collected in adults with long-standing
type 1 diabetes where no changes in hippocampal volume
have been observed (9). Hershey et al. speculate that the
developing brain may respond differently than the adult
brain to a hypoglycemic insult, which has been demon-
strated in animal models where postnatal age inﬂuences
the regional vulnerability to hypoglycemia (14).
Deﬁning the impact of diabetes and related risk factors
on cerebral structure and function is very important to
patients with diabetes. To do so will require careful
prospective evaluation of subjects with type 1 diabetes
over their life span using both sophisticated imaging
technology and comprehensive neurocognitive testing. As
depicted in Fig. 1, we must understand if the increases in
hippocampal volumes seen by Hershey et al. in children
with diabetes and frequent hypoglycemia are linked to the
abnormalities in white matter microstructure and neuro-
cognitive function identiﬁed by Kodl et al. (5) in popula-
tion of older type 1 diabetic subjects. Of equal importance
is learning whether the structural and neurocognitive
abnormalities identiﬁed in midlife in patients with type 1
diabetes are related to the more severe levels of cognitive
dysfunction seen in older subjects with type 2 diabetes
who also experience hypertension, hyperlipidemia, and
vascular disease. If so, we ultimately must determine
which interventions can be used to prevent this progres-
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upcoming years. For the sake of all people with diabetes,
we must not wait to see whether dementia is the expected
outcome in people growing old with diabetes before we
come to understand the full impact of the disease on the
brain.
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FIG. 1. Patients with diabetes have been found to have several changes in brain structure that appear to develop over time (top) and often
experience conditions that present risk for subsequent cognitive dysfunction (bottom). Future study is necessary to deﬁne the natural history,
structural basis, and risk factors for cognitive dysfunction in diabetes.
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